首页> 外文期刊>Cadernos de Saúde Pública >Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil
【24h】

Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil

机译:在巴西里约热内卢一个参考中心治疗的耐药性结核病(DR-TB)的随访损失和死亡相关因素

获取原文
       

摘要

Drug-resistant tuberculosis (DR-TB) poses a serious threat to tuberculosis (TB) control in Brazil and worldwide. The current study investigated factors associated with loss to follow-up and death in the course of treatment for DR-TB in a tertiary reference center in the city of Rio de Janeiro, Brazil. This was a retrospective cohort study of cases reported to the Information System on Special Treatments for Tuberculosis (SITETB) from January 1, 2012, to December 31, 2013. A total of 257 patients were reported to the SITETB and initiated treatment for DR-TB. Of this total, 139 (54.1%) achieved treatment success as the outcome, 54 (21%) were lost to follow-up, and 21 (8.2%) died. Following a multiple multinomial logistic regression analysis, the age bracket older than 50 years was the only protective factor against loss to follow-up, whereas less than eight years of schooling and reentry after loss to follow-up were considered risk factors. Reentry after loss to follow-up, relapse, and treatment failure appeared as risk factors. Our data reinforce the concept that loss to follow-up in drug-resistant tuberculosis is a serious public health problem, and that adequate follow-up of treatment is necessary in patients with this history and low schooling. A social support network for patients is also indispensable for avoiding unfavorable outcomes.
机译:耐药结核病(DR-TB)对巴西乃至全世界的结核病(TB)控制构成了严重威胁。本研究在巴西里约热内卢市的一个三级参考中心调查了在DR-TB治疗过程中失去随访和死亡的相关因素。这是一项回顾性队列研究,研究对象为2012年1月1日至2013年12月31日向结核病特殊治疗信息系统(SITETB)报告的病例。总共257名患者报告给SITETB并开始接受DR-TB的治疗。在全部患者中,有139名(54.1%)获得了成功的治疗结局,有54名(21%)失去随访,死亡21名(8.2%)。经过多项多项logistic回归分析后,年龄在50岁以上是防止失访的唯一保护因素,而失访后入学和入学少于8年被认为是危险因素。失去随访,复发和治疗失败后再入是危险因素。我们的数据强化了以下观念:耐药结核病失去随访是一个严重的公共卫生问题,对于有此病史和低学历的患者,有必要对治疗进行充分的随访。为避免不利的结果,患者的社会支持网络也是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号